Sunday, November 22, 2026
Village Voice News
ADVERTISEMENT
  • Home
  • News
  • Sports
  • Editorial
  • Letters
  • Global
  • Columns
    • Eye On Guyana
    • Hindsight
    • Lincoln Lewis Speaks
    • Future Notes
    • Blackout
    • From The Desk of Roysdale Forde SC
    • Diplomatic Speak
    • Mark’s Take
    • In the village
    • Mind Your Business
    • Bad & Bold
    • The Voice of Labour
    • The Herbal Section
    • Politics 101 with Dr. David Hinds
    • Talking Dollars & Making Sense
    • Book Review 
  • Education & Technology
  • E-Paper
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Sports
  • Editorial
  • Letters
  • Global
  • Columns
    • Eye On Guyana
    • Hindsight
    • Lincoln Lewis Speaks
    • Future Notes
    • Blackout
    • From The Desk of Roysdale Forde SC
    • Diplomatic Speak
    • Mark’s Take
    • In the village
    • Mind Your Business
    • Bad & Bold
    • The Voice of Labour
    • The Herbal Section
    • Politics 101 with Dr. David Hinds
    • Talking Dollars & Making Sense
    • Book Review 
  • Education & Technology
  • E-Paper
  • Contact Us
No Result
View All Result
Village Voice News
No Result
View All Result
Home Global

Cuban Drug HeberprotP Authorized For Clinical Trial in the US

Admin by Admin
May 5, 2024
in Global
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

teleSUR – The Cuban drug Heberprot-p received authorization for the development of a clinical trial in the U.S. . At the end of the year, the Biocubafarma Business Group announced on its Facebook page.

Biocubafarma explained that Discovery Therapeutics Caribe (DTC), an American company specialized in biotechnology, will be in charge of conducting clinical trials with this novel Cuban medicine to treat diabetic foot.

READ ALSO

UNITED STATES | Old Enough to Die, Too Young to Vote: The 100-Day Constitutional Amendment That Shamed America

FDA Announces Multiple Food Recalls Across US Over Contamination and Undeclared Allergens

As the Granma newspaper details “In the first quarter of 2024, DTC filed an application for a new investigational drug with the US Food and Drug Administration. USA. (FDA) , which included a Phase III protocol for a randomized, double-blind, placebo-controlled trial of Biocubafarma’s leading product.”

Granma also points out that although rhegf (rhegf) is already available in more than 20 countries, this is the first time it will be studied in American patients suffering from diabetic foot ulcers (UPD).

The Pan American Health Organization (PAHO) highlights that Heberprot-P is indicated, along with other conventional therapies, for the management of diabetic foot in patients with neuropathic and ischemic ulcers, in stages 3 and 4 of the Wagner classification.

“Some 426 232 patients have already used it in other nations after it was approved by Cuban authorities in 2006. But the US blockade against Cuba and the requirements to obtain commercial licenses have delayed the introduction of this drug in the US,” said the digital media Cubadebate.

The process of obtaining Heberprot-p is carried out by the Center for Genetic Engineering and Biotechnology (CIGB), and it is estimated that more than 400,000 patients with UPD have been administered this drug worldwide, since its commercial authorization in June 2006.

 

ShareTweetSendShareSend

Related Posts

Global

UNITED STATES | Old Enough to Die, Too Young to Vote: The 100-Day Constitutional Amendment That Shamed America

by Admin
November 22, 2026

The 26th Amendment to the U.S. Constitution is remembered as a rare moment of American unity. In truth it was...

Read moreDetails
Global

FDA Announces Multiple Food Recalls Across US Over Contamination and Undeclared Allergens

by Admin
November 21, 2026

Consumers across the United States are being urged to check their refrigerators, freezers and kitchen cupboards after a series of...

Read moreDetails
South African President Cyril Ramaphosa
Global

AFRICA | No Free Pass: Ramaphosa Tells Musk to Obey South Africa’s Laws or Stay Grounded

by Admin
November 20, 2026

South Africa’s president uses a Silicon Valley stage to tell the world’s richest man that Starlink enters on Pretoria’s terms,...

Read moreDetails
Next Post
Credit: Facebook

PPP Election Results: Jagdeo losing power, Ali beats him by 51 votes; Ramotar comes in almost bottom of list


EDITOR'S PICK

A screenshot from the livestream of the CCJ Hearing of the Application – N. Mohamed and A. Mohamed v Minister of Home Affairs, O. Walrond and others, on Tuesday 21 April 2026. [Image courtesy Caribbean Court of Justice YouTube Channel]

CCJ Weighs Bias, Warns Counsel- Reserves Judgment in Mohamed Extradition Case

April 23, 2026

Guyana Prize for Literature relaunched after more than 6 years with newer categories

September 7, 2022
[2/2] Barack Obama (L) and Dmitry Medvedev, who were then the U.S. and Russian presidents, sign the new Strategic Arms Reduction Treaty (START II) at Prague Castle in Prague April 8, 2010. REUTERS/Jason Reed/File Photo Purchase Licensing Rights

Russia says it regrets end of landmark nuclear treaty with US

February 5, 2026
Dr. David Hinds, WPA Co-leader

Use Oil Funds to Make UG a ‘Top Tier’ Research University- Dr. Hinds

February 18, 2026

© 2024 Village Voice

No Result
View All Result
  • Home
  • News
  • Sports
  • Editorial
  • Letters
  • Global
  • Columns
    • Eye On Guyana
    • Hindsight
    • Lincoln Lewis Speaks
    • Future Notes
    • Blackout
    • From The Desk of Roysdale Forde SC
    • Diplomatic Speak
    • Mark’s Take
    • In the village
    • Mind Your Business
    • Bad & Bold
    • The Voice of Labour
    • The Herbal Section
    • Politics 101 with Dr. David Hinds
    • Talking Dollars & Making Sense
    • Book Review 
  • Education & Technology
  • E-Paper
  • Contact Us

© 2024 Village Voice